A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-03-16

AUTHORS

Carlo Lancia, Jakob K. Anninga, Matthew R. Sydes, Cristian Spitoni, Jeremy Whelan, Pancras C. W. Hogendoorn, Hans Gelderblom, Marta Fiocco

ABSTRACT

PURPOSE: There is lack of consensus on the prognostic value of received high dose intensity in osteosarcoma survivorship. Many studies have not shown a clear survival benefit when dose intensity is increased. The aim of this study is to go beyond chemotherapy intensification by arm-wide escalation of intended dose and/or compression of treatment schedule, while conversely addressing the relationship between treatment intensity and survival at the patient level. The study focusses on the difference in outcome results, based on a novel, progressively more individualised approach to dose intensity. METHODS: A retrospective analysis of data from MRC BO06/EORTC 80931 randomised controlled trial for treatment of osteosarcoma was conducted. Three types of post hoc patient groups are formed using the intended regimen: the individually achieved cumulative dose and time on treatment, and the increase of individual cumulative dose over time. Event-free survival is investigated and compared in these three stratifications. RESULTS: The strata of intended regimen and achieved treatment yields equivalent results. Received cumulative dose over time produces groups with evident different survivorship characteristics. In particular, it highlights a group of patients with an estimated 3-year event-free survival much larger (more than 10%) than other patient groups. This group mostly contains patients randomised to an intensified regimen. In addition, adverse events reported by that group show the presence of increased preoperative myelotoxicity. CONCLUSIONS: The manuscript shows the benefits of analyzing studies by using longitudinal data, e.g. recorded per cycle. This has impact on the drafting of future trials by showing why such a level of detail is needed for both treatment and adverse event data. The novel method proposed, based on cumulative dose received over time, shows that longitudinal treatment data might be used to link survival outcome with drug metabolism. This is particularly valuable when pharmacogenetics data for metabolism of cytotoxic agents are not collected. TRIAL REGISTRATION: ISRCTN86294690. More... »

PAGES

1-12

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-019-03797-3

DOI

http://dx.doi.org/10.1007/s00280-019-03797-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112829552

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30879111


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Leiden University", 
          "id": "https://www.grid.ac/institutes/grid.5132.5", 
          "name": [
            "Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lancia", 
        "givenName": "Carlo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radboud University Nijmegen Medical Centre", 
          "id": "https://www.grid.ac/institutes/grid.10417.33", 
          "name": [
            "Department Paediatric Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anninga", 
        "givenName": "Jakob K.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MRC Clinical Trials Unit", 
          "id": "https://www.grid.ac/institutes/grid.415052.7", 
          "name": [
            "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL and MRC London Hub for Trials Methodology Research, 90 High Holborn, WC1V 6LJ, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sydes", 
        "givenName": "Matthew R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Center Utrecht", 
          "id": "https://www.grid.ac/institutes/grid.7692.a", 
          "name": [
            "Mathematical Institute Utrecht University, Budapestlaan 6, 3584 CD, Utrecht, The Netherlands", 
            "Department of Epidemiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Spitoni", 
        "givenName": "Cristian", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University College Hospital", 
          "id": "https://www.grid.ac/institutes/grid.439749.4", 
          "name": [
            "Department of Oncology, University College London Hospital, 235 Euston Rd, Fitzrovia, NW1 2BU, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Whelan", 
        "givenName": "Jeremy", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Leiden University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.10419.3d", 
          "name": [
            "Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hogendoorn", 
        "givenName": "Pancras C. W.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Leiden University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.10419.3d", 
          "name": [
            "Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gelderblom", 
        "givenName": "Hans", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Leiden University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.10419.3d", 
          "name": [
            "Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA, Leiden, The Netherlands", 
            "Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fiocco", 
        "givenName": "Marta", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/1097-0142(19940801)74:3+<1177::aid-cncr2820741529>3.0.co;2-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003187030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/md.0000000000004282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003966465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/md.0000000000004282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003966465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/md.0000000000004282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003966465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.40.9243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005702805"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-015-3418-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007752580", 
          "https://doi.org/10.1007/s10549-015-3418-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10555-009-9186-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010722520", 
          "https://doi.org/10.1007/s10555-009-9186-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10555-009-9186-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010722520", 
          "https://doi.org/10.1007/s10555-009-9186-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2013.11.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011640451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2011.09.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014802724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2011.09.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014802724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clgc.2016.03.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015427373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djk015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017995174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.12.1723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018298213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2015.118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022955193", 
          "https://doi.org/10.1038/bmt.2015.118"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-14-2638", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024910439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26472", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027084110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2010.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027115364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-3845", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028021708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.43.8598", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034492885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30214-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035951195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30214-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035951195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30214-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035951195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4419-0284-9_18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045378574", 
          "https://doi.org/10.1007/978-1-4419-0284-9_18"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4419-0284-9_18", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045378574", 
          "https://doi.org/10.1007/978-1-4419-0284-9_18"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-200027134", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052743984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.24.4028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074739291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.12.1935", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078512795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078763348", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.9.3137", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083316840"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-017-1036-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091508875", 
          "https://doi.org/10.1007/s12032-017-1036-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03-16", 
    "datePublishedReg": "2019-03-16", 
    "description": "PURPOSE: There is lack of consensus on the prognostic value of received high dose intensity in osteosarcoma survivorship. Many studies have not shown a clear survival benefit when dose intensity is increased. The aim of this study is to go beyond chemotherapy intensification by arm-wide escalation of intended dose and/or compression of treatment schedule, while conversely addressing the relationship between treatment intensity and survival at the patient level. The study focusses on the difference in outcome results, based on a novel, progressively more individualised approach to dose intensity.\nMETHODS: A retrospective analysis of data from MRC BO06/EORTC 80931 randomised controlled trial for treatment of osteosarcoma was conducted. Three types of post hoc patient groups are formed using the intended regimen: the individually achieved cumulative dose and time on treatment, and the increase of individual cumulative dose over time. Event-free survival is investigated and compared in these three stratifications.\nRESULTS: The strata of intended regimen and achieved treatment yields equivalent results. Received cumulative dose over time produces groups with evident different survivorship characteristics. In particular, it highlights a group of patients with an estimated 3-year event-free survival much larger (more than 10%) than other patient groups. This group mostly contains patients randomised to an intensified regimen. In addition, adverse events reported by that group show the presence of increased preoperative myelotoxicity.\nCONCLUSIONS: The manuscript shows the benefits of analyzing studies by using longitudinal data, e.g. recorded per cycle. This has impact on the drafting of future trials by showing why such a level of detail is needed for both treatment and adverse event data. The novel method proposed, based on cumulative dose received over time, shows that longitudinal treatment data might be used to link survival outcome with drug metabolism. This is particularly valuable when pharmacogenetics data for metabolism of cytotoxic agents are not collected.\nTRIAL REGISTRATION: ISRCTN86294690.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-019-03797-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "83"
      }
    ], 
    "name": "A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup", 
    "pagination": "1-12", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-019-03797-3"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "aba62e84f91efde8b68213aa3b79d636bb261fd5ed23ab70b5f288a5ea4286ec"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112829552"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30879111"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-019-03797-3", 
      "https://app.dimensions.ai/details/publication/pub.1112829552"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000376_0000000376/records_56176_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00280-019-03797-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03797-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03797-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03797-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03797-3'


 

This table displays all metadata directly associated to this object as RDF triples.

205 TRIPLES      21 PREDICATES      52 URIs      20 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-019-03797-3 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N5105a67b068d4cedbf5dde55f9f27ea3
4 schema:citation sg:pub.10.1007/978-1-4419-0284-9_18
5 sg:pub.10.1007/s10549-015-3418-z
6 sg:pub.10.1007/s10555-009-9186-7
7 sg:pub.10.1007/s12032-017-1036-9
8 sg:pub.10.1038/bmt.2015.118
9 https://app.dimensions.ai/details/publication/pub.1078763348
10 https://doi.org/10.1002/1097-0142(19940801)74:3+<1177::aid-cncr2820741529>3.0.co;2-7
11 https://doi.org/10.1002/cncr.26472
12 https://doi.org/10.1016/j.clgc.2016.03.014
13 https://doi.org/10.1016/j.critrevonc.2010.02.002
14 https://doi.org/10.1016/j.ctrv.2013.11.006
15 https://doi.org/10.1016/j.ejca.2011.09.012
16 https://doi.org/10.1016/s1470-2045(16)30214-5
17 https://doi.org/10.1081/cnv-200027134
18 https://doi.org/10.1093/jnci/djk015
19 https://doi.org/10.1097/md.0000000000004282
20 https://doi.org/10.1158/0008-5472.can-08-3845
21 https://doi.org/10.1158/1078-0432.ccr-14-2638
22 https://doi.org/10.1200/jco.1990.8.12.1935
23 https://doi.org/10.1200/jco.1998.16.9.3137
24 https://doi.org/10.1200/jco.2000.18.24.4028
25 https://doi.org/10.1200/jco.2007.12.1723
26 https://doi.org/10.1200/jco.2011.40.9243
27 https://doi.org/10.1200/jco.2012.43.8598
28 schema:datePublished 2019-03-16
29 schema:datePublishedReg 2019-03-16
30 schema:description PURPOSE: There is lack of consensus on the prognostic value of received high dose intensity in osteosarcoma survivorship. Many studies have not shown a clear survival benefit when dose intensity is increased. The aim of this study is to go beyond chemotherapy intensification by arm-wide escalation of intended dose and/or compression of treatment schedule, while conversely addressing the relationship between treatment intensity and survival at the patient level. The study focusses on the difference in outcome results, based on a novel, progressively more individualised approach to dose intensity. METHODS: A retrospective analysis of data from MRC BO06/EORTC 80931 randomised controlled trial for treatment of osteosarcoma was conducted. Three types of post hoc patient groups are formed using the intended regimen: the individually achieved cumulative dose and time on treatment, and the increase of individual cumulative dose over time. Event-free survival is investigated and compared in these three stratifications. RESULTS: The strata of intended regimen and achieved treatment yields equivalent results. Received cumulative dose over time produces groups with evident different survivorship characteristics. In particular, it highlights a group of patients with an estimated 3-year event-free survival much larger (more than 10%) than other patient groups. This group mostly contains patients randomised to an intensified regimen. In addition, adverse events reported by that group show the presence of increased preoperative myelotoxicity. CONCLUSIONS: The manuscript shows the benefits of analyzing studies by using longitudinal data, e.g. recorded per cycle. This has impact on the drafting of future trials by showing why such a level of detail is needed for both treatment and adverse event data. The novel method proposed, based on cumulative dose received over time, shows that longitudinal treatment data might be used to link survival outcome with drug metabolism. This is particularly valuable when pharmacogenetics data for metabolism of cytotoxic agents are not collected. TRIAL REGISTRATION: ISRCTN86294690.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N23cba3a652ab42e199674ce9c8333e27
35 Naa0376fc482749c4ad6ace014a077386
36 sg:journal.1088364
37 schema:name A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup
38 schema:pagination 1-12
39 schema:productId N0e04778c82774d99add1d75c4950e7dd
40 N16f41f046a4f4348981e8849ea032ff1
41 N30968f69990c4d04ba0ab5904db725b8
42 N99c6312a658e48b58795538aa1e5a2a2
43 Na0e69acfbf0a4147904c82158c705b05
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112829552
45 https://doi.org/10.1007/s00280-019-03797-3
46 schema:sdDatePublished 2019-04-15T09:19
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N2ca621b161ce47389dbdd9a9dcff96e8
49 schema:url https://link.springer.com/10.1007%2Fs00280-019-03797-3
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N010c8593daf544a5ae7759c1f093fd78 schema:affiliation https://www.grid.ac/institutes/grid.10419.3d
54 schema:familyName Hogendoorn
55 schema:givenName Pancras C. W.
56 rdf:type schema:Person
57 N04f60fc0b0924c6da1b65435519c103b schema:affiliation https://www.grid.ac/institutes/grid.10419.3d
58 schema:familyName Fiocco
59 schema:givenName Marta
60 rdf:type schema:Person
61 N0e04778c82774d99add1d75c4950e7dd schema:name doi
62 schema:value 10.1007/s00280-019-03797-3
63 rdf:type schema:PropertyValue
64 N16f41f046a4f4348981e8849ea032ff1 schema:name nlm_unique_id
65 schema:value 7806519
66 rdf:type schema:PropertyValue
67 N23cba3a652ab42e199674ce9c8333e27 schema:volumeNumber 83
68 rdf:type schema:PublicationVolume
69 N2ca621b161ce47389dbdd9a9dcff96e8 schema:name Springer Nature - SN SciGraph project
70 rdf:type schema:Organization
71 N2d703d45074a4ac989f2a01a8245f4a0 schema:affiliation https://www.grid.ac/institutes/grid.10419.3d
72 schema:familyName Gelderblom
73 schema:givenName Hans
74 rdf:type schema:Person
75 N30968f69990c4d04ba0ab5904db725b8 schema:name readcube_id
76 schema:value aba62e84f91efde8b68213aa3b79d636bb261fd5ed23ab70b5f288a5ea4286ec
77 rdf:type schema:PropertyValue
78 N30e6a50529f947d2bf13f21ed020d594 schema:affiliation https://www.grid.ac/institutes/grid.415052.7
79 schema:familyName Sydes
80 schema:givenName Matthew R.
81 rdf:type schema:Person
82 N5105a67b068d4cedbf5dde55f9f27ea3 rdf:first Naa3b0c55252b470ab9a43bf4d69ad568
83 rdf:rest Nd4f972de385c48548d90aea48a2bd34a
84 N542719574ec7464a96392c82d278552e rdf:first Nb04891263f234db9ac1b2683cfbb6689
85 rdf:rest Ne3a55e1afb5f471c87d17b53e81486e6
86 N714bd53690204984956b0071b1d05f2f rdf:first N010c8593daf544a5ae7759c1f093fd78
87 rdf:rest N80d3f612a12e4253b20cdb2c441f6b56
88 N78a0fa6aa14142da95cd473f832c9756 rdf:first N30e6a50529f947d2bf13f21ed020d594
89 rdf:rest N542719574ec7464a96392c82d278552e
90 N80d3f612a12e4253b20cdb2c441f6b56 rdf:first N2d703d45074a4ac989f2a01a8245f4a0
91 rdf:rest N9832eb3acafa486789a2d59702f242b1
92 N9832eb3acafa486789a2d59702f242b1 rdf:first N04f60fc0b0924c6da1b65435519c103b
93 rdf:rest rdf:nil
94 N99c6312a658e48b58795538aa1e5a2a2 schema:name dimensions_id
95 schema:value pub.1112829552
96 rdf:type schema:PropertyValue
97 Na0e69acfbf0a4147904c82158c705b05 schema:name pubmed_id
98 schema:value 30879111
99 rdf:type schema:PropertyValue
100 Naa0376fc482749c4ad6ace014a077386 schema:issueNumber 5
101 rdf:type schema:PublicationIssue
102 Naa3b0c55252b470ab9a43bf4d69ad568 schema:affiliation https://www.grid.ac/institutes/grid.5132.5
103 schema:familyName Lancia
104 schema:givenName Carlo
105 rdf:type schema:Person
106 Nb04891263f234db9ac1b2683cfbb6689 schema:affiliation https://www.grid.ac/institutes/grid.7692.a
107 schema:familyName Spitoni
108 schema:givenName Cristian
109 rdf:type schema:Person
110 Nc44ffc93bf8b4a8fa74cbc7b3a6583dc schema:affiliation https://www.grid.ac/institutes/grid.10417.33
111 schema:familyName Anninga
112 schema:givenName Jakob K.
113 rdf:type schema:Person
114 Nd4f972de385c48548d90aea48a2bd34a rdf:first Nc44ffc93bf8b4a8fa74cbc7b3a6583dc
115 rdf:rest N78a0fa6aa14142da95cd473f832c9756
116 Ne3a55e1afb5f471c87d17b53e81486e6 rdf:first Ne86348e486e04c53acc2a9000eb106d3
117 rdf:rest N714bd53690204984956b0071b1d05f2f
118 Ne86348e486e04c53acc2a9000eb106d3 schema:affiliation https://www.grid.ac/institutes/grid.439749.4
119 schema:familyName Whelan
120 schema:givenName Jeremy
121 rdf:type schema:Person
122 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
123 schema:name Medical and Health Sciences
124 rdf:type schema:DefinedTerm
125 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
126 schema:name Clinical Sciences
127 rdf:type schema:DefinedTerm
128 sg:journal.1088364 schema:issn 0344-5704
129 1432-0843
130 schema:name Cancer Chemotherapy and Pharmacology
131 rdf:type schema:Periodical
132 sg:pub.10.1007/978-1-4419-0284-9_18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045378574
133 https://doi.org/10.1007/978-1-4419-0284-9_18
134 rdf:type schema:CreativeWork
135 sg:pub.10.1007/s10549-015-3418-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1007752580
136 https://doi.org/10.1007/s10549-015-3418-z
137 rdf:type schema:CreativeWork
138 sg:pub.10.1007/s10555-009-9186-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010722520
139 https://doi.org/10.1007/s10555-009-9186-7
140 rdf:type schema:CreativeWork
141 sg:pub.10.1007/s12032-017-1036-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091508875
142 https://doi.org/10.1007/s12032-017-1036-9
143 rdf:type schema:CreativeWork
144 sg:pub.10.1038/bmt.2015.118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022955193
145 https://doi.org/10.1038/bmt.2015.118
146 rdf:type schema:CreativeWork
147 https://app.dimensions.ai/details/publication/pub.1078763348 schema:CreativeWork
148 https://doi.org/10.1002/1097-0142(19940801)74:3+<1177::aid-cncr2820741529>3.0.co;2-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003187030
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1002/cncr.26472 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027084110
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/j.clgc.2016.03.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015427373
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/j.critrevonc.2010.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027115364
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/j.ctrv.2013.11.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011640451
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/j.ejca.2011.09.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014802724
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/s1470-2045(16)30214-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035951195
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1081/cnv-200027134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052743984
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1093/jnci/djk015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017995174
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1097/md.0000000000004282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003966465
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1158/0008-5472.can-08-3845 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028021708
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1158/1078-0432.ccr-14-2638 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024910439
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1200/jco.1990.8.12.1935 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078512795
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1200/jco.1998.16.9.3137 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083316840
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1200/jco.2000.18.24.4028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074739291
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1200/jco.2007.12.1723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018298213
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1200/jco.2011.40.9243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005702805
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1200/jco.2012.43.8598 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034492885
183 rdf:type schema:CreativeWork
184 https://www.grid.ac/institutes/grid.10417.33 schema:alternateName Radboud University Nijmegen Medical Centre
185 schema:name Department Paediatric Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands
186 rdf:type schema:Organization
187 https://www.grid.ac/institutes/grid.10419.3d schema:alternateName Leiden University Medical Center
188 schema:name Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
189 Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
190 Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
191 Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA, Leiden, The Netherlands
192 rdf:type schema:Organization
193 https://www.grid.ac/institutes/grid.415052.7 schema:alternateName MRC Clinical Trials Unit
194 schema:name MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL and MRC London Hub for Trials Methodology Research, 90 High Holborn, WC1V 6LJ, London, UK
195 rdf:type schema:Organization
196 https://www.grid.ac/institutes/grid.439749.4 schema:alternateName University College Hospital
197 schema:name Department of Oncology, University College London Hospital, 235 Euston Rd, Fitzrovia, NW1 2BU, London, UK
198 rdf:type schema:Organization
199 https://www.grid.ac/institutes/grid.5132.5 schema:alternateName Leiden University
200 schema:name Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA, Leiden, The Netherlands
201 rdf:type schema:Organization
202 https://www.grid.ac/institutes/grid.7692.a schema:alternateName University Medical Center Utrecht
203 schema:name Department of Epidemiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
204 Mathematical Institute Utrecht University, Budapestlaan 6, 3584 CD, Utrecht, The Netherlands
205 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...